CD19/BCMA CAR-T for SLE

Clinical trial NCT07266337 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07266337
Sponsor: Chengdu Ucello Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus

Start date: 2025-12-10
Primary completion: 2035-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.